Together for improved health care and less animal testing

VitalTissue gives human residual tissues that become available after surgery a new purpose as valuable material for scientific research. This way VitalTissue contributes to the health of the citizens of the Netherlands. VitalTissue has no profit motive.
Our goal? Making human residual tissues accessible for scientific research through a network of participating hospitals, thereby accelerating medical innovations, speeding up development of better medicine and reducing the dependence on animal testing.

VitalTissue collaborates with Isala Hospital Zwolle.

VitalTissue contracted the following research institutions:

  • Amsterdam UMC (AMC and VUMC locations),
  • University of Groningen (RuG),
  • Wageningen University and Research (WUR),
  • Utrecht University of Applied Sciences (HU),
  • University Medical Center Utrecht (UMCU),
  • Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek (TNO),
  • National Institute for Public Health and the Environment (RIVM),
  • Chiron On-Chip Biotechnologies B.V.,
  • Danone Research & Innovation,
  • Mimetas B.V.,
  • Technische Universiteit Eindhoven (TU/e),
  • VU Amsterdam.

VitalTissue conducts contract negotiations with the following research institutions:

  • Utrecht University (UU),
  • Universiteit van Amsterdam (UvA).

VitalTissue is a division of:

Partners:

New campaign

VitalTissue takes residual tissue further

Starting June 2026, we are working on expanding our network of hospitals and medical professionals who provide residual tissue, as well as researchers who use this vital residual tissue for their groundbreaking research. To support this, we have created a new brochure and several social media ads featuring some of our stakeholders sharing their experiences with VitalTissue. We would like to thank them sincerely for their contribution. Curious to learn more? Visit our campaign page.

VitalTissue. This is how it works

Often, not all tissue that is removed in surgery is needed for diagnostics and/or follow-up research. This residual tissue is usually destroyed. That is a pity, because human residual tissue offers great opportunities for scientific research to improve and accelerate drug development. VitalTissue makes this fresh tissue accessible to researchers in The Netherlands for existing and the development of new experimental models that better match human biology. As a consequence progression in medical research will be accelerated and dependence on animal testing will be reduced.

News

Testimonial Corné Baatenburg de Jong – Reuma Nederland

Testimonial Corné Baatenburg de Jong – Reuma Nederland

“VitalTissue als onderdeel van ETB-BISLIFE is voor ReumaNederland van essentieel belang!” stelt Corné Baatenburg de Jong - Adjunct Directeur ReumaNederland. "Waarom? Een goede samenwerking tussen verschillende stakeholders is essentieel voor de ontwikkeling van...

read more
Testimonial Sue Gibbs – Amsterdam UMC en ACTA

Testimonial Sue Gibbs – Amsterdam UMC and ACTA

“Restweefsel uit de OK’s is de toekomst van biomedisch onderzoek.” Het gebruik van diermodellen in biomedisch onderzoek is niet alleen dieronvriendelijk, maar levert helaas ook resultaten op die lastig te vertalen zijn naar de mens. Daarom zet ik me al jaren in voor...

read more
Testimonial Jetty van Ginkel – Managing Director hDMT

Testimonial Jetty van Ginkel – Managing Director hDMT

"Om de transitie naar proefdiervrije innovatie écht vorm te geven, is de toegang tot kwalitatief menselijk restweefsel cruciaal. VitalTissue speelt hierbij een onmisbare rol” stelt dr Jetty van Ginkel, Managing Director, hDMT. “Bij hDMT faciliteren en ondersteunen we...

read more

Interested?

VitalTissue
[email protected]
Jan van Krimpenweg 17
2031 CG Haarlem